J Dequesne

No ORCID on file · 10 papers in corpus
article 2009

peer reviewed

article 2007
·doi:10.1007/s10397-007-0296-3
article 1996
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(96)80159-9

The first laparoscopic hysterectomy was performed in our center in November 1990. From then until March 1994 I performed 107 procedures. The indications were the same as for abdominal hysterectomy, such as abnormal uterine bleeding (fibroid…

article 1995
·doi:10.1016/s1074-3804(05)80494-3
article 1994
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(05)80898-9

Since 1985, more than 500 CO2 laser laparoscopic procedures have been done, including treatment of endometriosis, adhesiolysis, salpingo-ovariolysis and salpingoneostomy. The most frequent indication was endometriosis. The results were as f…

article 1994
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(05)80899-0

Medical reduction of the endometrium before hysteroscopic procedures has been demonstrated by many authors. In endometrial ablation, the GnRH agonists are useful for endometrial reduction and correction of anemia preoperatively. However, in…

article 1994
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(05)80897-7

After enthusiastic reports in the late 1980s, many authors are disappointed by the long term results of endometrectomy. In our first series of 75 patients, all followed for at least 60 months, we have had 71% good results, including treatme…

article 1989
·doi:10.1089/gyn.1989.5.177

This long-term study involves 160 patients, referred for hysterectomy, who complained of uterine bleeding that was resistant to conventional treatment. Before surgery, these patients had a diagnostic hysteroscopy that showed that the bleedi…

book-chapter 1987
·doi:10.1159/000414869

Six patients suffering from endometriosis (Acosta stages I to III) were treated by luteinizing hormone-releasing hormone agonists (LHRH-A). In 3 of the 6 patients buserelin (Hoechst AG, FRG) was subcutaneously infused using an osmotic minip…

article 1987
·doi:10.1007/bf02594138